''GAS6/AXL PATHWAY IS ACTIVATED IN CHRONIC LIVER DISEASE AND ITS TARGETING REDUCES FIBROSIS VIA HEPATIC STELLATE CELL INACTIVATION.''
Our research is devoted to the study of the molecular mechanisms of cell death and proliferation, as they are involved in the development of different human pathologies.